Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 277

Results For "company"

3886 News Found

Jubilant Pharmova to acquire stake in Greencure
News | April 03, 2022

Jubilant Pharmova to acquire stake in Greencure

There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution


Jenburkt Wellness launches D2C brand Zixa strong
Healthcare | April 03, 2022

Jenburkt Wellness launches D2C brand Zixa strong

The organization has introduced an advanced FlashMicelle technology which is a combination of ultra-rapid mixing techniques, and a uniquely powerful approach to modify the structure of oil-based formulations to improve their therapeutic efficacy substantially


USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
Biotech | April 03, 2022

USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma

Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --


Dr. Reddy's and MediCane Health launch medical cannabis in Germany
Biotech | April 03, 2022

Dr. Reddy's and MediCane Health launch medical cannabis in Germany

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021


WHO selects Biological E for mRNA tech transfer
News | April 03, 2022

WHO selects Biological E for mRNA tech transfer

Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer


Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
Biotech | April 01, 2022

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product


Arzeda closes US$33 million Series B funding
Digitisation | April 01, 2022

Arzeda closes US$33 million Series B funding

Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology


Sumitomo Chemical to build new API and intermediates plant in Japan
News | April 01, 2022

Sumitomo Chemical to build new API and intermediates plant in Japan

The plant is scheduled to come on stream in September 2024


Evonik restructures health care business
News | April 01, 2022

Evonik restructures health care business

The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries